Marc Pierre Lavergne
Aventis Pharma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marc Pierre Lavergne.
Bioorganic & Medicinal Chemistry Letters | 2003
Michel Tabart; Guy Picaut; Marc Pierre Lavergne; Sylvie Wentzler; Jean-Luc Malleron; Sylvie Dutka-Malen; Nadine Berthaud
The synthesis and antibacterial activity of benzo[f][1,7]naphtyridone derivatives are reported. These compounds are potent antibacterial agents with a Gram-positive spectrum of activity. They are active against multi-resistant cocci, especially Staphylococcus aureus strains. Their physico-chemical and biological properties make them particularly suitable for topical antibacterial use.
Archive | 1992
Eric Bacque; Michel Barreau; Jean-Francois Desconclois; Philippe Girard; Michel Kryvenko; Marc Pierre Lavergne; Jean-Marc Paris; Guy Picaut
Archive | 1992
Michel Barreau; Michel Kryvenko; Marc Pierre Lavergne; Auguste Techer
Archive | 2001
Jean-Francois Desconclois; Arielle Genevois-Borella; Philippe Girard; Michel Kryvenko; Marc Pierre Lavergne; Jean-Luc Malleron; Guy Picaut; Michel Tabart; Sylvie Wentzler
Archive | 1992
Michel Barreau; Michel Kryvenko; Marc Pierre Lavergne; Auguste Techer
Archive | 2000
Jean-Francois Desconclois; Arielle Genevois-Borella; Philippe Girard; Michel Kryvenko; Marc Pierre Lavergne; Jean-Luc Malleron; Guy Picaut; Michel Tabart; Sylvie Wentzler
Archive | 1992
Michel Barreau; Michel Kryvenko; Marc Pierre Lavergne; Auguste Techer
Archive | 1991
Michel Barreau; Michel Kryvenko; Marc Pierre Lavergne; Auguste Techer
Archive | 2003
Jean-Francois Desconclois; Arielle Genevois-Borella; Philippe Girard; Michel Kryvenko; Marc Pierre Lavergne; Jean-Luc Malleron; Guy Picaut; Michel Tabart; Sylvie Wentzler
Archive | 1994
Eric Bacque; Michel Barreau; Jean-Franqois Desconclois; Philippe Girard; Michel Kryvenko; Marc Pierre Lavergne; Jean-Marc Paris; Guy Picaut